February 01, 2017
A New York federal judge on Wednesday withdrew her order to transfer to Massachusetts three suits alleging Keryx Biopharmaceuticals Inc. hid supply chain problems prior to a stock drop, after a New York shareholder accused Massachusetts investors of improperly looking to bring the cases to a friendlier forum.